BCR-ABL-IN-8 (compound 26f) is a BCR-ABL inhibitor containing trimethoxy group.
References:
[1]. Liang X, et al. Discovery of 2-((3-Amino-4-metlphenyl)amino)-N-(2-metl-5-(3-(trifluorometl)benzamido)phenyl)-4-(metlamino)pyrimidine-5-carboxamide (CHMFL-ABL-053) as a Potent, Selective, and Orally Available BCR-ABL/SRC/p38 Kinase Inhibitor for Chronic Myeloid Leukemia. J Med Chem. 2016 Mar 10;59(5):1984-2004.